AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
92 hedge funds and large institutions have $676M invested in Aimmune Therapeutics in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
24% more funds holding
Funds holding: 74 → 92 (+18)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
92
Holding in Top 10
5
Calls
$684K
Puts
$207K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$8.34M | |
| 3 | +$6.72M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.39M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$6.31M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$8.92M | |
| 3 | -$2.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.56M |
| 5 |
CCI
Columbus Circle Investors
|
-$918K |